Finance

Lists
3347:HKG
Hangzhou Tigermed Consulting Ord Shs H
HK$41.26
-1.57%
(-0.66) 1D
Sep 11, 3:07:05 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3347...
Open
HK$40.02
High
HK$41.98
Low
HK$40.02
Mkt. cap
50.17B
Avg. vol.
0.00
Volume
1.01M
Dividend
0.35%
Quarterly dividend
HK$0.04
Ex-dividend date
Jul 10, 2026
P/E ratio
279.54
52-wk high
HK$57.00
52-wk low
HK$28.12
EPS
HK$0.15
No. of employees
12K
Open
HK$40.02
High
HK$41.98
Low
HK$40.02
Mkt. cap
50.17B
Avg. vol.
0.00
Volume
1.01M
Dividend
0.35%
Quarterly dividend
HK$0.04
Ex-dividend date
Jul 10, 2026
P/E ratio
279.54
52-wk high
HK$57.00
52-wk low
HK$28.12
EPS
HK$0.15
No. of employees
12K
About Hangzhou Tigermed Consulting Ord Shs H
CEO-
Employees12K
FoundedDec 15, 2004
Headquarters-
SectorHealth care
Last report
Aug 27, 2026
Fiscal period
Q2 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
1.91B / 1.88B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.78B
1.81B
1.80B
1.91B
Cost of goods sold
1.29B
1.40B
1.32B
1.37B
Cost of revenue
1.29B
1.40B
1.32B
1.37B
Research and development expenses
64.24M
66.40M
62.66M
76.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
243.09M
254.27M
229.62M
233.37M
Operating expense
291.54M
341.05M
301.46M
315.21M
Total operating expenses
1.58B
1.74B
1.62B
1.68B
Operating income
196.09M
66.53M
178.43M
225.41M
Other non operating income
-2.09M
-3.03M
-
-7.88M
EBT including unusual items
780.09M
-219.57M
405.94M
-486.16M
EBT excluding unusual items
385.85M
40.87M
192.93M
168.12M
Income tax expense
51.24M
67.06M
75.86M
29.40M
Effective tax rate
6.57%
-30.54%
18.69%
-6.05%
Other operating expenses
-15.03M
32.47M
6.70M
8.15M
Net income
637.10M
-132.54M
49.04M
-462.20M
Net profit margin
35.88%
-7.34%
2.72%
-24.25%
Earnings per share
-
-
-
-
Interest and investment income
198.80M
8.72M
36.66M
-
Interest expense
-21.76M
-14.40M
-22.16M
-39.84M
Net interest expenses
177.04M
-5.68M
14.50M
-39.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
247.40M
119.49M
231.39M
281.14M
Gain or loss from assets sale
625.76K
-3.65M
-
18.08M
AI content may include mistakes. Learn more
Google apps